Elise Brett is an Endocrinology/Metabolic physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 41 publications with 4,042 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1192 Park Ave
New York, NY 101281314
Telephone
212-831-2100Provider last certified this registry record 5 Jun 2024.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ascendis Pharma Endocrinology IncProgram year20259 payments$11,797openpaymentsdata.cms.gov ↗
- Fresenius Kabi USA, LLCProgram year20251 payment
- Xeris Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
53.4%GLP-1 receptor agonist16.8%Ozempic52%Mounjaro28%Trulicity11%Rybelsus9%Part D≥84 patientsBiguanide (metformin)12.9%Metformin Hcl Er59%Metformin Hcl42%Part D≥112 patients+ 9 more classes in this area
Hormonal (systemic)
25.6%l-Thyroxine23.8%Levothyroxine Sodium57%Synthroid39%Tirosint2%Levoxyl1%Tirosint-Sol1%Part D<11 patientsThyroid Hormone Synthesis Inhibitor0.9%Methimazole100%Part D<11 patients+ 3 more classes in this area
Cardiovascular
19%Statin7.3%Atorvastatin Calcium64%Rosuvastatin Calcium28%Simvastatin5%Pravastatin Sodium4%Part D<11 patientsAngiotensin receptor blocker (ARB)2.8%Losartan Potassium55%Irbesartan24%Valsartan-Hydrochlorothiazide12%Losartan-Hydrochlorothiazide9%Part D<11 patients+ 11 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”